Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Tips for overcoming experience gap, building a diverse workforce
When Ariel Banks graduated from the University of Missouri at Rolla in 2014 with a chemical engineering degree, she felt qualified and eager to jump into her career. Unfortunately, Banks spent nearly two years without any luck in finding a job. She found herself being asked time and time again, the dreaded question: “What is…
Wonder no more: Ruby Jean’s taking juice to Troost
Thirty years after Chris Goode’s grandmother helped drop him off for daycare at Operation Breakthrough on Troost Avenue, the entrepreneur is expanding the juicery that bears her name — Ruby Jean’s — to a site less than a block away. “It’s crazy how life comes full circle,” said Goode, Ruby Jean’s Juicery founder. “I’m 33 now…
5 startups enjoy growth, connections with KCMO innovation partnership
Although the government may be pegged as resistant to change, Kansas City Mayor Sly James wants to flip the script. “On a city level, we aren’t having much help from the state and federal governments sometimes,” James said at the Innovation Partnership Program demo day on Monday at WeWork Corrigan Station. “But, we still have…
With fund now slashed, LaunchKC alumni say MTC vital to early success
PopBookings probably wouldn’t be in business today without the early support — and more critically the investment dollars — of the Missouri Technology Corporation, Erika Klotz said. “It really allowed us to do more quicker,” the PopBookings co-founder and CEO said. “For any startup, speed is everything. It allowed us to get credibility right out…